Walleye Trading LLC Novartis Ag Transaction History

Walleye Trading LLC

$46 Billion
Q4 2024

A detailed history of Walleye Trading LLC transactions in Novartis Ag stock. As of the latest transaction made, Walleye Trading LLC holds 23,015 shares of NVS stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,015

Previous 616 3636.2%

Holding current value

$2.56 Million

Previous $70,000 3098.57%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$96.78 - $117.18 $2.17 Million - $2.62 Million	22,399 Added 3636.2%	23,015 $2.24 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $80,340 - $91,513	-757 Reduced 55.13%	616 $70,000
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $811,376 - $941,098	-8,765 Reduced 86.46%	1,373 $146,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $2.74 Million - $3.11 Million	-28,715 Reduced 73.91%	10,138 $980,000
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $790,661 - $870,096	-8,569 Reduced 18.07%	38,853 $3.92 Million
Q3 2023 Nov 21, 2023	BUY	$94.73 - $105.13 $4.49 Million - $4.99 Million	47,422 New	47,422 $4.83 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $41,200 - $57,722	-583 Reduced 6.46%	8,444 $696,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $81,064 - $93,767	1,211 Added 15.49%	9,027 $778,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $116,123 - $131,241	1,789 Added 29.68%	7,816 $590,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $240,381 - $287,372	-3,415 Reduced 36.17%	6,027 $487,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $700,029 - $729,583	9,442	9,442 $811,000

Others Institutions Holding NVS

# of Institutions

1,479

Shares Held

134M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $240B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account

Walleye Trading LLC Novartis Ag Transaction History